Home » Stocks » NeuroBo Pharmaceuticals

NeuroBo Pharmaceuticals, Inc. (NRBO)

Stock Price: $6.30 USD -0.11 (-1.72%)
Updated Aug 3, 2020 1:21 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 103.49M
Revenue (ttm) n/a
Net Income (ttm) -22.24M
Shares Out 16.43M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $6.30
Previous Close $6.41
Change ($) -0.11
Change (%) -1.72%
Day's Open 6.44
Day's Range 6.30 - 6.66
Day's Volume 19,899
52-Week Range 6.02 - 30.00

More Stats

Market Cap 103.49M
Enterprise Value 93.79M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 16.43M
Float 2.48M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.53
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 200,805
Short Ratio 2.76
Short % of Float 6.87%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 13.92
Revenue n/a
Operating Income -22.71M
Net Income -22.24M
Free Cash Flow -8.22M
Net Cash 9.70M
Net Cash / Share 0.59
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -35.62%
ROE -421.04%
ROIC 1,170.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$20.00*
Low
20.0
Current: $6.30
High
20.0
Target: 20.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-20.18-15.49-33.13-14.70-8.08-0.27
Net Income-21.31-15.53-33.42-14.59-9.03-0.32
Shares Outstanding5.224.250.410.230.120.06
Earnings Per Share-4.08-3.65-80.75-64.25-113.50-5.25
Operating Cash Flow-7.04-14.45-26.90-11.04-5.43-0.20
Capital Expenditures-0.21-----
Free Cash Flow-7.25-14.45-26.90-11.04-5.43-0.20
Cash & Equivalents13.922.8518.4824.043.620.00
Total Debt0.120.1410.04-6.42-
Net Cash / Debt13.812.708.4424.04-2.800.00
Assets14.473.8219.0224.754.49-
Liabilities2.180.3615.084.128.92-
Book Value12.29-13.293.9420.63-12.38-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name NeuroBo Pharmaceuticals, Inc.
Country United States
Employees 12
CEO Jeong Gu Kang

Stock Information

Ticker Symbol NRBO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: NRBO

Description

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.